| scholarly article | Q13442814 |
| P2093 | author name string | Smith DA | |
| Beasley R | |||
| McHaffie DJ | |||
| P2860 | cites work | An equation for prediction of energy expenditure of walking and running | Q69517315 |
| Digoxin dosage and ventricular rate at rest and exercise in patients with atrial fibrillation | Q70612950 | ||
| Digitalis | Q70901867 | ||
| Determination of Therapeutic and Toxic Serum Digoxin Concentrations by Radioimmunoassay | Q71341003 | ||
| Evidence of vagal neuropathy in chronic alcoholics | Q72435867 | ||
| The Use of Digitalis Glycosides in Sinus Rhythm | Q37855995 | ||
| Human cardiovascular adjustments to exercise and thermal stress | Q39934157 | ||
| The Beneficial Effects of Verapamil in Chronic Atrial Fibrillation | Q41666106 | ||
| Beta-adrenergic blockade as adjunctive oral therapy in patients with chronic atrial fibrillation | Q45265639 | ||
| The time course during 36 weeks' endurance training of changes in Vo2 max. and anaerobic threshold as determined with a new computerized method. | Q64967945 | ||
| P433 | issue | 6461 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | digoxin | Q422222 |
| Atrial Fibrillation | Q815819 | ||
| P304 | page(s) | 9-11 | |
| P577 | publication date | 1985-01-01 | |
| P1433 | published in | The BMJ | Q546003 |
| P1476 | title | Exercise heart rates at different serum digoxin concentrations in patients with atrial fibrillation | |
| P478 | volume | 290 |
| Q37783198 | Atrial fibrillation. The therapeutic options |
| Q36232441 | Atrial fibrillation: how to approach rate control |
| Q34345947 | Beta-adrenoceptor blockers in atrial fibrillation: the importance of partial agonist activity |
| Q39612740 | Calcium channel antagonists. Part III: Use and comparative efficacy in hypertension and supraventricular arrhythmias. Minor indications |
| Q43726592 | Clinical pharmacology of chronic atrial fibrillation. |
| Q35772224 | Computational approaches to structural and functional analysis of plastocyanin and other blue copper proteins. |
| Q39383560 | Incidence of digoxin toxicity in outpatients. |
| Q41989836 | Influence of physical exercise on serum digoxin concentration and heart rate in patients with atrial fibrillation |
| Q50755775 | Modulation of ventricular rate in permanent atrial fibrillation: randomized, crossover study of the effects of slow-release formulations of gallopamil, diltiazem, or verapamil. |
| Q34978723 | New approaches to atrial fibrillation management: a critical review of a rapidly evolving field. |
| Q33640719 | Pharmacological control of rate and maintenance of sinus rhythm |
| Q34821575 | Prevention of and medical therapy for atrial arrhythmias in heart failure. |
| Q35166383 | Rate control in atrial fibrillation: choice of treatment and assessment of efficacy |
| Q35773042 | Rate control in the medical management of atrial fibrillation |
| Q46167374 | Rate versus rhythm control with and without heart failure |
| Q37712119 | Serum concentration monitoring of cardiac glycosides. How helpful is it for adjusting dosage regimens? |
| Q41840056 | The drug treatment of atrial fibrillation |
| Q41308335 | The value of therapeutic drug monitoring to the practising physician--an hypothesis in need of testing |
| Q33610685 | Time of occurrence, duration, and ventricular rate of paroxysmal atrial fibrillation: the effect of digoxin |
| Q39476042 | Treatment of nonvalvular atrial fibrillation |
| Q33610558 | What is meant by a "controlled" ventricular rate in atrial fibrillation? |
Search more.